Image For Activity Cover
Study 309/Keynote-775: A Randomized, Phase 3 Study to Compare the Efficacy and Safety of Lenvatinib with Pembrolizumab vs Treatment of Physician’s Choice in Advanced Endometrial Cancer
Description

Recorded Live: May 10, 2022

Presenter
Vicky Makker, MD
USA

Summary
Availability: On-Demand
Cost: FREE
Recommended
Contact education@igcs.org for assistance.
Powered By